Psychotropic drug prescription in patients with dementia: Nursing home residents versus patients living at home

Journal of Alzheimer's Disease

Volumn 49, Issue 3, 2015, Pages 671-680

  Jacquin Piques, Agnes ^a   Sacco, Guillaume ^b   Tavassoli, Neda ^c   Rouaud, Olivier ^a   Bejot, Yannick ^a   Giroud, Maurice ^a   Robert, Philippe ^b   Vellas, Bruno ^c   Bonin Guillaume, Sylvie ^d  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b University of Côte d Azur   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

Dementia; National Alzheimer's data Bank; Nursing home; Psychotropic drug

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

AGED; ARTICLE; COMMUNITY LIVING; CROSS-SECTIONAL STUDY; DATA BASE; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NURSING HOME PATIENT; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; SCORING SYSTEM; VERY ELDERLY; CHI SQUARE DISTRIBUTION; DEMOGRAPHY; FACTUAL DATABASE; NURSING HOME; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DEMENTIA; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; NURSING HOMES; PSYCHOTROPIC DRUGS; RESIDENCE CHARACTERISTICS;

EID: 84949977030     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150280     Document Type: Article

References (39)

1. Rolland Y, Andrieu S, Crochard A, Goni S, Hein C, Vellas B (2012) Psychotropic drug consumption at admission and discharge of nursing home residents. J Am Med Dir Assoc 13, 407 e7-12.
2. Morley JE Clinical practice in nursing homes as a key for progress. (2010) J Nutr Health Aging 14, 586-593.
3. Rolland Y, Abellan van Kan G, Hermabessiere, Her-mabessiere S, Gerard S, Guyonnet Gillette S, Vellas B (2009) Descriptive study of nursing home residents from the REHPA network. J Nutr Health Aging 13, 679-683.
4. Tolson D, Rolland Y, Andrieu S, Aquino JP, Beard J, Benetos A, Berrut G, Coll-Planas L, Dong B, Forette F, Franco A, Franzoni S, Salvà A, Swagerty D, Trabucchi M, Vellas B, Volicer L, Morley JE, The International Association of Gerontology, Geriatrics/World Health Organization/Society Française de Gérontologie et de Gériatrie Task Force (2011) International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes. J Am Med Dir Assoc 12, 184-189.
5. Rolland Y, Aquino JP, Andrieu S, Beard J, Benetos A, Berrut G, Coll-Planas L, Dartigues JF, Dong B, Forette F, Franco A, Franzoni S, Hornez T, Metais P, Ruault G, Stephan E, Swagerty D, Tolson D, Volicer L, Vellas B, Morley J (2011) Identification of the main domains for quality of care and clinical research in nursing homes. J Nutr Health Aging 15, 410-424.
6. Doshi JA, Shaffer T, Briesacher BA (2005) National estimates of medication use in nursing homes: Findings from the 1997 Medicare current beneficiary survey and the 1996 medical expenditure survey. J Am Geriatr Soc 53, 438-443.
7. Hosia-Randell H, Pitkala K (2005) Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging 22, 793-800.
8. Mann E, Köpke S, Haastert B, Mann E, Kopke S, Haastert B (2009) Psychotropic medication use among nursing home residents in Austria: A cross-sectional study. BMC Geriatr 9, 18.
9. Chen Y, Briesacher BA, Field TS, Tjia J, Lau DT, Gurwitz JH (2011) Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med 170, 89-95.
10. Kamble P, Chen H, Sherer JT, Aparasu RR (2009) Use of antipsychotics among elderly nursing home residents with dementia in the US: An analysis of National Survey Data. Drugs Aging 26, 483-492.
11. Tjia J, Rothman MR, Kiely DK, Shaffer ML, Holmes HM, Sachs GA, Mitchell SL (2010) Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc 58, 880-888.
12. Rochon PA, Stukel TA, Bronskill SE, Gomes T, Sykora K, Wodchis WP, Hillmer M, Kopp A, Gurwitz JH, Anderson GM (2007) Variation in nursing home antipsychotic prescribing rates. Arch Intern Med 167, 676-683.
13. Bronskill SE, Rochon PA, Gill SS, Herrmann N, Hillmer MP, Bell CM, Anderson GM, Stukel TA (2009) The relationship between variationsinantipsychoticprescribing acrossnursing homes and short-term mortality: Quality of care implications. Med Care 47, 1000-1008.
14. Snowdon J, Day S, Baker W (2005) Why and how antipsy-chotic drugs are used in 40 Sydney nursing homes. Int J Geriatr Psychiatry 20, 1146-1152.
15. Richter T, Mann E, Meyer G, Haastert B, Köpke S (2012) Prevalence of psychotropic medication use among German and Austrian nursing home residents: A comparison of 3 cohorts. J Am Med Dir Assoc 13, 187. e7-187. e13.
16. Gellad WF, Aspinall SL, Handler SM, Stone RA, Castle N, Semla TP, Good CB, Fine MJ, Dysken M, Hanlon JT (2012) Use of antipsychotics among older residents in VA Nursing Homes. Med Care 11, 954-960.
17. Bloch F, Thibaud M, Dugué B, Brèque C, Rigaud AS, Kemoun C (2011) Psychotropic drugs and falls in the elderly people: Updated literature review and meta-analysis. J Aging Health 23, 329-346.
18. Cabrera MA, Dellaroza MS, Trelha CS, Paccola LB, da Cruz Domiciano Perdigão S, de Barros Pinto ME, Silva TJ, de Oliveira DG (2010) Psychoactive drugs as risk factors for functional decline among noninstitutionalized dependent elderly people. J Am Med Dir Assoc 11, 519-522.
19. Schneider LS, Dagermann KS, Insel P (2005) Risk of death with atypical antipsychotic drug treatment for dementia. Meta-analysis of randomized placebo-controlled trials. J Am Med Assoc 294, 1934-1943.
20. Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA (2007) Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 146, 775-586.
21. Gardette V, Lapeyre-Mestre M, Coley N, Cantet C, Mon-tastruc JL, Vellas B, Andrieu S (2012) Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: Evidence for a role of dementia severity. Curr Alzheimer Res 9, 1106-1116.
22. Haute Autorité de Santé. Diagnostic and management of Alzheimer's diseaseand relateddisorders. Professional guidelines. Mars 2008. Available at: http://www.has-sante.fr
23. Haute Autorité de Santé. Programme AMI-Alzheimer: Alerte et Maitrise de la Iatrogénie des Neurolep-tiques dans la Maladie d'Alzheimer 2007. Available at: http://www.has-sante.fr/portail/jcms/c 891528/programme-ami-alerte-maitrise-iatrogenie-alzheimer.
24. LeDuff F, Develay AE, Quetel J, Lafay P, Schück S, Pradier C, Robert P, French National Alzheimer dataBank (BNA) (2012) The 2008-2012 French Alzheimer Plan: Description of the national Alzheimer information system. J Alzheimers Dis 29, 891-902.
25. Tifratene K, Le Duff F, Pradier C, Quetel J, Lafay P, Schück S, Benzenine E, Quantin C, Robert P (2012) Use of drug treatments for Alzheimer's disease in France: A study on a national level based on the national Alzheimer's Data Bank (Banque Nationale Alzheimer). Pharmaco Drug Safety 21, 1005-1012.
26. Parsons C, Johnston S, Mathie E, Baron N, Machen I, Amador S, Goodman C (2012) Potentially inappropriate prescribing in older people with dementia in care homes: A retrospective analysis. Drugs Aging 29, 143-155.
27. Shah SM, Carey IM, Harris T, Dewilde S, Cook DG (2011) Antipsychotic prescribingtoolder people livingincare homes and the community in England and Wales. Int J Geriatr Psychiatry 26, 423-434.
28. Jalbert JJ, Eaton CB, Miller SC, Lapane KL (2010) Antipsy-chotic use and the risk of hip fracture among older adults afflicted with dementia. J Am Med Dir Assoc 11, 120-127.
29. Mann E, Haastert B, Böhmdorfer B, Frühwald T, Iglseder B, Roller-Wirnsberger R, Meyer G (2013) Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: Secondary analysis of a cross-sectional study. Wien Klin Wochenstr 125, 180-188.
30. Peter Str M, Cedilnik Gorup E (2011) Psychotropic medication use among elderly nursing home residents in Slovenia: Cross-sectional study. Croat Med J 52, 16-24.
31. Gauthier S, Feldman H, Hecker J (2002) Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. Int Psychogeriatr 14, 389-404.
32. Cummings JL, Schneider L, Tariot PN, Kersha PR, Yuan W (2004) Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease. Am J Psychiatry 161, 532-538.
33. Cummings JL, Koumaras B, Chen M, Mirski D, Rivastigmine Nursing Home Study Team (2005) Effects of rivastigmine treatmentonthe neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: A 26-week, multicenter, open-label study. Am J Geriatr Pharmacother 3, 137-148.
34. Cummings JL, Schneider E, Tariot PN, Graham SM, Meman-tine MEM-MD-02 Study Group (2006) Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology 67, 57-63.
35. Bullock R (2006) Efficacy and safety of memantine in moderate to severe Alzheimer disease: The evidence to date. Alzheimer Dis Assoc Disord 20, 23-29.
36. Gauthier S, Loft H, Cummings JL (2008) Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: A pooled data analysis. Int J Geriatr Psychiatry 23, 537-545.
37. Grossberg GT, Pejovic V, Miller ML, Graham SM (2009) Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease. Dement Geriatr Cogn Disord 27, 164-172.
38. Gitlin LN, Kales HC, Lyketsos CG (2012) Nonpharmacologic management ofbehavioral symptomsindementia. JAMA 308, 2020-2029.
39. Cummings JL, McPherson S (2001) Neuropsychiatric assessment of Alzheimer's disease and related dementias. Aging 13, 240-246.